InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,711.09
(
0.03%
)
US TECH 100
19,308.35
(
0.16%
)
Dow Jones
42,104.74
(
-0.22%
)
Brent Oil
77.01
(
3.20%
)
Bitcoin
60,453.98
(
-0.28%
)
Post# of 253269
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jb_118

Send PM Follow Ignore
Followers 0
Posts 253
Boards Moderated 0
Alias Born 03/01/2006

jb_118

Re: lgonber post# 214572

Wednesday, 10/25/2017 11:54:14 AM

Wednesday, October 25, 2017 11:54:14 AM

Post# of 253269
Re: MGNX - INCY collaboration

In addition to the upfront $150M, MGNX also eligible for $750 in biobucks, and tiered royalties on sales from 15-24%. INCY will handle the development.


"Per the terms of the collaboration, MacroGenics will also be eligible to receive up to $420 million in potential development and regulatory milestones, and up to $330 million in potential commercial milestones. If MGA012 is approved and commercialized, MacroGenics would be eligible to receive royalties, tiered from 15 percent to 24 percent, on future sales of MGA012 by Incyte."

https://finance.yahoo.com/news/incyte-macrogenics-announce-global-collaboration-104500627.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up